| Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial JS Smolen, A Beaulieu, A Rubbert-Roth, C Ramos-Remus, J Rovensky, ... The Lancet 371 (9617), 987-997, 2008 | 1779 | 2008 |
| Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research … K Visser, W Katchamart, E Loza, JA Martinez-Lopez, C Salliot, J Trudeau, ... Annals of the rheumatic diseases 68 (7), 1086-1093, 2009 | 662 | 2009 |
| Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial D Khanna, CJF Lin, DE Furst, J Goldin, G Kim, M Kuwana, Y Allanore, ... The Lancet Respiratory Medicine 8 (10), 963-974, 2020 | 449 | 2020 |
| Baricitinib, methotrexate, or combination in patients with rheumatoid arthritis and no or limited prior disease‐modifying antirheumatic drug treatment R Fleischmann, M Schiff, D van der Heijde, C Ramos‐Remus, A Spindler, ... Arthritis & Rheumatology 69 (3), 506-517, 2017 | 422 | 2017 |
| Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological … D van der Heijde, JCC Wei, M Dougados, P Mease, A Deodhar, ... The Lancet 392 (10163), 2441-2451, 2018 | 354 | 2018 |
| Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty‐two–week, randomized, controlled study D van der Heijde, HSB Baraf, C Ramos‐Remus, A Calin, AL Weaver, ... Arthritis & Rheumatism 52 (4), 1205-1215, 2005 | 323 | 2005 |
| Identifying clinical trials in the medical literature with electronic databases: MEDLINE alone is not enough ME Suarez-Almazor, E Belseck, J Homik, M Dorgan, C Ramos-Remus Controlled clinical trials 21 (5), 476-487, 2000 | 249 | 2000 |
| Treatment of lupus nephritis with abatacept: the abatacept and cyclophosphamide combination efficacy and safety study ACCESS Trial Group Arthritis & Rheumatology 66 (11), 3096-3104, 2014 | 236 | 2014 |
| Efficacy and safety of ixekizumab in the treatment of radiographic axial spondyloarthritis: sixteen‐week results from a phase III randomized, double‐blind, placebo‐controlled … A Deodhar, D Poddubnyy, C Pacheco‐Tena, C Salvarani, ... Arthritis & rheumatology 71 (4), 599-611, 2019 | 231 | 2019 |
| Efficacy and safety of epratuzumab in moderately to severely active systemic lupus erythematosus: results from two phase III randomized, double‐blind, placebo‐controlled trials MEB Clowse, DJ Wallace, RA Furie, MA Petri, MC Pike, P Leszczyński, ... Arthritis & rheumatology 69 (2), 362-375, 2017 | 224 | 2017 |
| Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: A randomized, double‐blind trial J Braun, IE van der Horst‐Bruinsma, F Huang, R Burgos‐Vargas, ... Arthritis & Rheumatism 63 (6), 1543-1551, 2011 | 216 | 2011 |
| Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial A Deodhar, D van der Heijde, LS Gensler, TH Kim, WP Maksymowych, ... The Lancet 395 (10217), 53-64, 2020 | 215 | 2020 |
| Cardiac manifestations in dermato-polymyositis. L Gonzalez-Lopez, JI Gamez-Nava, L Sanchez, E Rosas, ... Clinical and experimental rheumatology 14 (4), 373-379, 1996 | 128 | 1996 |
| Frequency of atlantoaxial subluxation and neurologic involvement in patients with ankylosing spondylitis. C Ramos-Remus, A Gomez-Vargas, JL Guzman-Guzman, F Jimenez-Gil, ... The Journal of rheumatology 22 (11), 2120-2125, 1995 | 123 | 1995 |
| A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis LS Lohmander, D McKeith, O Svensson, M Malmenäs, L Bolin, A Kalla, ... Annals of the rheumatic diseases 64 (3), 449-456, 2005 | 120 | 2005 |
| Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis. S Bahlas, C Ramos-Remus, P Davis The Journal of Rheumatology 25 (1), 99-104, 1998 | 115 | 1998 |
| Low tear production in patients with diabetes mellitus is not due to Sjögren's syndrome. C Ramos-Remus, M Suarez-Almazor, AS Russell Clinical and experimental rheumatology 12 (4), 375-380, 1994 | 98 | 1994 |
| Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism. L Gonzalez-Lopez, JI Gamez-Nava, GS Jhangri, C Ramos-Remus, ... The Journal of rheumatology 26 (3), 540-545, 1999 | 89 | 1999 |
| Genotoxicity assessment using micronuclei assay in rheumatoid arthritis patients C Ramos-Remus, G Dorazco-Barragan, FJ Aceves-Avila, ... Clinical and experimental rheumatology 20 (2), 208-212, 2002 | 83 | 2002 |
| How important is patient education? C Ramos-Remus, AL Salcedo-Rocha, RE Prieto-Parra, F Galvan-Villegas Best Practice & Research Clinical Rheumatology 14 (4), 689-703, 2000 | 79 | 2000 |
